Cipla, Dr Reddy’s Lab, Mondelez & Unilever lauded for transition to fourth industrial revolution using advanced technologies despite global challenges like Ukraine war & Covid.
Dr Reddy's, through which Russia's Sputnik V is available in India, said the timeline was pushed a little further due to import dependency, quality checks.
Originally intended for cancer, Dr Reddy’s 2-DG works by preventing the supply of glucose molecules to cancerous cells, which need glucose for survival.
The drug was tested on 40 patients during phase 2 trials. But, the govt’s expert panel found the sample size ‘inadequate’ to approve the drug for marketing in India.
Dr Reddy’s had proposed to test Sputnik V in a Phase III clinical trial that generally needs to enroll over 1,000 participants. Govt panel has recommended a smaller trial instead.
RDIF will supply 100 million doses of Sputnik V — the Covid vaccine developed by Russian researchers — in India once it has received all the regulatory clearances.
Country's used lithium-ion battery problem is also set to grow sharply in next decade. India 3rd largest e-waste producer with 7% global share but currently recycles only about 10% of it.
Shield AI will provide V-BAT vertical takeoff & landing drones along with licences for software, which will be integrated into aircraft and made available to select Indian partners.
No nation other than China can negotiate one-on-one with Trump on an equal footing. That’s why the middle powers who so far formed the core of multilateral bodies now feel orphaned.
COMMENTS